Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 8805925

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
1996 Apr
First author
Rothenberg ML

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 1996 Apr;7(4):333-4. doi: 10.1093/oxfordjournals.annonc.a010596.
    note
    Source null
    related pmid
    8805921
    relationship
    Comment in
  2. citation
    Ann Oncol. 1996 Apr;7(4):335-7. doi: 10.1093/oxfordjournals.annonc.a010597.
    note
    Source null
    related pmid
    8805922
    relationship
    Comment in

Authors and identifiers

  1. name
    Rothenberg ML
    type
    Author
  2. name
    Moore MJ
    type
    Author
  3. name
    Cripps MC
    type
    Author
  4. name
    Andersen JS
    type
    Author
  5. name
    Portenoy RK
    type
    Author
  6. name
    Burris HA 3rd
    type
    Author
  7. name
    Green MR
    type
    Author
  8. name
    Tarassoff PG
    type
    Author
  9. name
    Brown TD
    type
    Author
  10. name
    Casper ES
    type
    Author
  11. name
    Storniolo AM
    type
    Author
  12. name
    Von Hoff DD
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Rothenberg ML
    type
    Author
  2. name
    Moore MJ
    type
    Author
  3. name
    Cripps MC
    type
    Author
  4. name
    Andersen JS
    type
    Author
  5. name
    Portenoy RK
    type
    Author
  6. name
    Burris HA 3rd
    type
    Author
  7. name
    Green MR
    type
    Author
  8. name
    Tarassoff PG
    type
    Author
  9. name
    Brown TD
    type
    Author
  10. name
    Casper ES
    type
    Author
  11. name
    Storniolo AM
    type
    Author
  12. name
    Von Hoff DD
    type
    Author
bibliography ids
  1. nci-bib-ba88e4c144577915853f84de
book metadata
content sha256
e6d56991920ebad9d22d6e38552870ec1e7b19f62e52e4dcda4666e5b48049ef
document type
citation
dois
  1. 10.1093/oxfordjournals.annonc.a010600
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:8805925
immutable id
pubmed:8805925@e6d56991920ebad9d22d6e38552870ec1e7b19f62e52e4dcda4666e5b48049ef
journal
abbreviation
Ann Oncol
issn electronic
Source null
issn print
0923-7534
issue
4
name
Annals of oncology : official journal of the European Society for Medical Oncology
nlm unique id
9007735
pages
347-53
volume
7
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 1996 Apr;7(4):333-4. doi: 10.1093/oxfordjournals.annonc.a010596.
    note
    Source null
    related pmid
    8805921
    relationship
    Comment in
  2. citation
    Ann Oncol. 1996 Apr;7(4):335-7. doi: 10.1093/oxfordjournals.annonc.a010597.
    note
    Source null
    related pmid
    8805922
    relationship
    Comment in
outcomes validated
false
pmid
8805925
provenance
batch id
2752791f8cc3526b9192
provider
NCBI PubMed ESummary
record sha256
26c36353da4d135ddbac7dd3a94b8579f99ec7fb58b6e19696dce3bbaaa4b459
response sha256
8db42d042a938e99e944b9e6af6caf1dd877725c05485e70efac12add1ee08e9
retrieved at
2026-09-09T23:45:25.088603+00:00
publication date
display
1996 Apr
precision
month
year
1996
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/8805925/
title
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.

Preserved source evidence · Not medical advice